Myron Wentz
Founder at USANA HEALTH SCIENCES, INC.
Net worth: 382 M $ as of 30/03/2024
Myron Wentz active positions
| Companies | Position | Start | End |
|---|---|---|---|
| USANA HEALTH SCIENCES, INC. | Director/Board Member | 30/04/2020 | - |
| Founder | 31/08/1992 | - | |
| Chief Executive Officer | 31/08/1992 | 22/07/2008 | |
| Chairman | 31/08/1992 | - |
Career history of Myron Wentz
Former positions of Myron Wentz
| Companies | Position | Start | End |
|---|---|---|---|
| IMMUNOSYN CORP | Director/Board Member | 13/03/2008 | 19/03/2009 |
Gull Laboratories, Inc.
 Gull Laboratories, Inc. Medical SpecialtiesHealth Technology Part of Meridian Bioscience, Inc., Gull Laboratories, Inc. is a private company that specializes in surgical and medical instruments as well as drugs. The company is based in Salt Lake City, UT. The company was founded by Myron W. Wentz. Gull Laboratories was acquired by Meridian Bioscience, Inc. from Fresenius SE & Co. KGaA on November 05, 1998 for $18.04 million. | Chairman | 31/12/1973 | 31/12/1997 |
| Founder | 31/12/1973 | 31/12/1997 | |
| Sanoviv SA de CV | Founder | 31/12/1997 | - |
Training of Myron Wentz
| University of Utah | Doctorate Degree |
| North Central College | Undergraduate Degree |
| University of North Dakota | Graduate Degree |
Statistics
International
| United States | 7 |
| Mexico | 2 |
Operational
| Founder | 3 |
| Director/Board Member | 2 |
| Chairman | 2 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| USANA HEALTH SCIENCES, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Gull Laboratories, Inc.
Gull Laboratories, Inc. Medical SpecialtiesHealth Technology Part of Meridian Bioscience, Inc., Gull Laboratories, Inc. is a private company that specializes in surgical and medical instruments as well as drugs. The company is based in Salt Lake City, UT. The company was founded by Myron W. Wentz. Gull Laboratories was acquired by Meridian Bioscience, Inc. from Fresenius SE & Co. KGaA on November 05, 1998 for $18.04 million. | Health Technology |
Immunosyn Corp.
 Immunosyn Corp. BiotechnologyHealth Technology Immunosyn Corp. is a development stage company. It engages in the marketing, distribution, and sale of a biopharmaceutical drug product SF-1019, which is used for the treatment of various diseases and pathological conditions, including chronic inflammatory demyelinating polyneuropathy, diabetic neuropathy, and diabetic ulcers. The company was founded in August 2006 and is headquartered in San Diego, CA. | Health Technology |
| Sanoviv SA de CV |
- Stock Market
- Insiders
- Myron Wentz
- Experience
